Efforts to Invigorate the General Shareholders’  Meeting and Facilitate Smooth Exercise of  Voting Rights Accounting Audit Seeking to invigorate its General Shareholders’ Meeting,  the Company sends out convocation notices three weeks  in advance of its annual General Shareholders’ Meeting.  We also hold such meetings on days when there is no  concentration of other companies’ shareholders’ meetings.  To enhance the environment for the exercise of voting  rights, meanwhile, we utilize an electronic voting platform  operated by a joint venture in which the Tokyo Stock  Exchange and other entities own equity stakes.  Ernst & Young ShinNihon LLC serves as the Company’s  Accounting Auditor. The Accounting Auditor and the  Company’s Corporate Auditors maintain close cooperation  by meeting several times a year. At these meetings, they  discuss their annual audit plans and the results of audits,  and they share important audit information. Furthermore, to  ensure the reliability of financial reporting, the Company has  established and is operating an internal control system for  financial reporting that complies with standards generally  accepted in Japan, and assesses the effectiveness of the  system as appropriate. Astellas also prepares an English translation of its con- vocation notices and makes both the Japanese original  and its English translation available on its corporate website. Astellas recognizes that the timely and appropriate disclo- sure of corporate information underpins the creation of a  healthy capital market. The Company has established the  Disclosure Policy based on its policy to make timely and  fair disclosure of accurate corporate information concern- ing financial results and other matters to participants of  capital markets and the news media in accordance with  laws, regulations and listing regulations. The Company has put into practice a group-wide system  to promote honest corporate activities firmly rooted in a  disciplined and sound corporate culture. The Company has  established an internal control system in every part of the  group and will further establish, develop and enhance sys- tems, such as the system to improve work efficiency, the  risk management system, the system for compliance with  laws and other matters, and the internal audit system, as  well as promote systems and an environment for ensuring  that audits by Corporate Auditors are carried out effectively.  Through these efforts, the Company is working to ensure  that the entire Astellas group’s business is duly executed. The Company has established the IR Committee, with  the aim of implementing proper IR activities for investors. The  IR Committee discusses matters, such as the disclosure of  material information, pursuant to the Disclosure Policy. The Company’s main IR activities in fiscal 2013 included  holding regular briefings on financial results for securities  analysts, institutional investors and news media, as well as  participation in conferences held by securities companies  both in Japan and overseas. In Japan, we also held briefings  for individual shareholders and other individual investors. Details on this system of internal controls are available  on the Company’s Web site, and in the reports concerning  corporate governance submitted to the stock exchanges, etc. Corporate Governance Annual Report 2014 _  Astellas Pharma Inc.  79 (¥ million) Accounting Auditor’s compensation in fiscal 2013 165 Total amount of cash and other material benefits payable to Accounting Auditor by the Company and its subsidiaries 193 Disclosure of Information Measures to Improve the Internal Control  System